The issuance of a new patent is generally a positive event for a biotech company like Bolt Biotherapeutics. It strengthens the company's intellectual property portfolio, potentially giving it a competitive edge in the market. This could lead to increased investor confidence and a potential short-term increase in the company's stock price.